US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Adia Nutrition, Inc.

0.1990

-0.0109-5.19%

Volume:15.08K

Turnover:2.90K

Market Cap:18.79M

PE:-100.86

High:0.1990

Open:0.1500

Low:0.1500

Close:0.2099

52wk High:0.2777

52wk Low:0.0125

Shares:94.40M

Float Shares:94.40M

Volume Ratio:2.57

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0020

EPS(LYR):0.0000

ROE:-1460.81%

ROA:-32.76%

PB:-194.54

PE(LYR):-24,875.00

Loading ...

Overview Company News Filings

Adia Nutrition Names Dr. Brian Browning Lead Physician for Orthopedic Treatments

Foreign Capital Is Returning to Hong Kong Stocks in a Big Way

Adia Nutrition Promotes Emmanuela Derisbrun to Provider Role

Adia Nutrition Names Dawn Bell Chief Revenue Officer

Adia Nutrition Reports Over 200% Revenue Growth and Advances Toward Nasdaq Uplisting

Adia Nutrition Inc. Secures IRB Approval for Autism Clinical Study

GIC and ADIA-backed Vantage Data Centres finalises acquisition of Johor data centre and US$1.6 bil funding led by SWFs

Adia Nutrition Inc. Hosts Webinar on HSCT for MS and Autoimmune Conditions

Snam - Termination Will Not Impact 2025 Guidance

THOMSON REUTERS

Snam - Termination Involves 24.99% Stake in Open Grid Europe

THOMSON REUTERS

Snam - Snam and Adia Terminate Agreement Relating to Open Grid Europe Stake

THOMSON REUTERS

Adia Nutrition Partners with AxiaMD to Expand Regenerative Therapies Nationwide

Adia Nutrition Reports Over 200% Quarterly Revenue Growth and Advances Toward Nasdaq Listing

Adia Nutrition Reports Over 200% Revenue Growth and 20% Profit Margin in Q3

Adia Nutrition Inc. Appoints Dr. Evan Thomas as Medical Director

Adia Nutrition Inc reports third quarter revenue more than doubles profit margin exceeds 20 percent

Adia Nutrition Sells Biolete Coffee to Cement Factory LLC, Retains 18% Stake to Focus on Regenerative Medicine Expansion

PAI Partners Closes $4.2 Billion Froneri Equity Deal Backed by Goldman Sachs, ADIA

MT Newswires Live

Press Release: OHA Secures Significant Commitment from ADIA for European Special Situations Strategy

Adia Nutrition Inc. Announces Share Cancellation to Strengthen Capital Structure Amid Ongoing Legal Proceedings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ADIA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADIA\",,,,,undefined,":{"symbol":"ADIA","market":"US","secType":"STK","nameCN":"Adia Nutrition, Inc.","latestPrice":0.199,"timestamp":1770998865888,"preClose":0.2099,"halted":0,"volume":15075,"delay":15,"changeRate":-0.05192949023344446,"floatShares":94404700,"shares":94404700,"eps":-0.001973,"marketStatus":"Trading","change":-0.0109,"latestTime":"02-13 11:07:45 EST Delay","open":0.15,"high":0.199,"low":0.15,"amount":2904.29,"amplitude":0.233444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.001973,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771016400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.2099,"volumeRatio":2.566632},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADIA\",,,,,undefined,":{"symbol":"ADIA","floatShares":94404700,"roa":"-32.76%","roe":"-1460.81%","lyrEps":-0.000008,"volumeRatio":2.566632,"shares":94404700,"dividePrice":0,"high":0.199,"amplitude":0.233444,"preClose":0.2099,"low":0.15,"week52Low":0.0125,"pbRate":"-194.54","psRate":"2944.60","week52High":0.27767,"institutionHeld":0,"latestPrice":0.199,"eps":-0.001973,"divideRate":0,"volume":15075,"delay":15,"ttmEps":-0.001973,"open":0.15,"prevYearClose":0.078,"prevWeekClose":0.185,"prevMonthClose":0.2346,"prevQuarterClose":0.078,"fiveDayClose":0.185,"twentyDayClose":0.1145,"sixtyDayClose":0.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADIA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADIA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADIA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608862195","title":"Adia Nutrition Names Dr. Brian Browning Lead Physician for Orthopedic Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2608862195","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608862195?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:02","pubTimestamp":1770040935,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on February 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL4Kd5mZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIA","BK4183"],"gpt_icon":0},{"id":"1150603542","title":"Foreign Capital Is Returning to Hong Kong Stocks in a Big Way","url":"https://stock-news.laohu8.com/highlight/detail?id=1150603542","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150603542?lang=en_us&edition=fundamental","pubTime":"2026-01-18 21:41","pubTimestamp":1768743713,"startTime":"0","endTime":"0","summary":"Mainstream international long-only funds have returned to participating in equity financing and issuance projects for Chinese companies. Goldman Sachs recently noted that the participation rate of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIA","BK4183"],"gpt_icon":0},{"id":"2603981274","title":"Adia Nutrition Promotes Emmanuela Derisbrun to Provider Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2603981274","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603981274?lang=en_us&edition=fundamental","pubTime":"2026-01-16 00:04","pubTimestamp":1768493061,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. has promoted Emmanuela Derisbrun, APRN, FNP-C, from subcontractor to employed provider at its medical division, Adia Med, to support growing patient demand and the launch of its autism spectrum disorder regenerative study.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on January 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL2V4T7l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"gpt_icon":0},{"id":"2601536215","title":"Adia Nutrition Names Dawn Bell Chief Revenue Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601536215","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601536215?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:31","pubTimestamp":1767879084,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. has appointed Dawn Bell as Chief Revenue Officer through its subsidiary, ADIA Labs. Bell brings over 15 years of experience in sales strategy within the medical device and pharmaceutical sectors. She will focus on driving growth and supporting physicians and clinics in integrating ADIA's regenerative therapies and diagnostic services.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on January 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDLpSPc2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"gpt_icon":0},{"id":"2595733447","title":"Adia Nutrition Reports Over 200% Revenue Growth and Advances Toward Nasdaq Uplisting","url":"https://stock-news.laohu8.com/highlight/detail?id=2595733447","media":"Reuters","labels":["corporation","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595733447?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:01","pubTimestamp":1767016882,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc.  reported significant business milestones and financial results for 2025. The company achieved a successful uplisting from OTC Pink to the OTCQB Venture Market in six weeks and completed SEC Rule 15c2-11 compliance. Preliminary and confirmed Q3 results indicated revenue growth of over 200% quarter-over-quarter, with earlier reports showing more than 100% growth and profit margins exceeding 20%. The sales force was tripled, and four regional sales divisions were established. Adia became a preferred vendor for the PI Doctors Elite Community, gaining access to over 4,000 personal injury physicians and the $50 billion personal injury care market. The company launched a national television marketing campaign and divested its Biolete Coffee subsidiary while retaining an 18% equity stake. Adia also progressed in negotiations for in-network status with major insurance providers and filed an SEC Form 10, with Nasdaq uplisting approval expected in early 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL3y5d0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIA","BK4183"],"gpt_icon":0},{"id":"2591640124","title":"Adia Nutrition Inc. Secures IRB Approval for Autism Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2591640124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591640124?lang=en_us&edition=fundamental","pubTime":"2025-12-15 23:30","pubTimestamp":1765812656,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. has received approval from the independent Institutional Review Board  BeyondBound for its clinical study protocol focused on Autism Spectrum Disorder . The approved study, led by Adia Med of Winter Park LLC, will enroll 100 children ages 3-12 to investigate the therapeutic benefits of combining glutathione with umbilical cord blood-derived stem cells compared to glutathione alone. The study has been submitted to ClinicalTrials.gov and is in final review before becoming publicly visible. No grant or funding from multiple organizations is mentioned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on December 15, 2025, and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL6VmTW6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIA","BK4183"],"gpt_icon":0},{"id":"2586919412","title":"GIC and ADIA-backed Vantage Data Centres finalises acquisition of Johor data centre and US$1.6 bil funding led by SWFs","url":"https://stock-news.laohu8.com/highlight/detail?id=2586919412","media":"Daoyi Lin","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586919412?lang=en_us&edition=fundamental","pubTime":"2025-11-24 03:23","pubTimestamp":1763925829,"startTime":"0","endTime":"0","summary":"Once fully developed, the campus will deliver more than 300MW of IT capacity across three data centres.\n","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/data-centres/gic-and-adia-backed-vantage-data-centres-finalises-acquisition-johor-data-centre?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/data-centres/gic-and-adia-backed-vantage-data-centres-finalises-acquisition-johor-data-centre?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["ADIA","BK4183","BK4104","GIC"],"gpt_icon":0},{"id":"2584947688","title":"Adia Nutrition Inc. Hosts Webinar on HSCT for MS and Autoimmune Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2584947688","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584947688?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:32","pubTimestamp":1763562771,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. will participate in a live webinar on November 20, 2025, at 6:30 PM EST, hosted by HSCT Warriors. During the event, Dr. Evan Thomas, Medical Director of Adia Med, will present on Hematopoietic Stem Cell Transplantation  for multiple sclerosis and other autoimmune conditions, focusing on the science, patient outcomes, and Adia Med's physician-led, compliant approach to offering this therapy in the U.S.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on November 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL5HDJWg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"gpt_icon":0},{"id":"2583684059","title":"Snam - Termination Will Not Impact 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2583684059","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583684059?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:37","pubTimestamp":1763156235,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WQ1EW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIA","BK4183"],"gpt_icon":0},{"id":"2583684044","title":"Snam - Termination Involves 24.99% Stake in Open Grid Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2583684044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583684044?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:37","pubTimestamp":1763156235,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WQ1EW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIA","BK4183"],"gpt_icon":0},{"id":"2583568404","title":"Snam - Snam and Adia Terminate Agreement Relating to Open Grid Europe Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2583568404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583568404?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:37","pubTimestamp":1763156235,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WQ1EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ADIA"],"gpt_icon":0},{"id":"2582872583","title":"Adia Nutrition Partners with AxiaMD to Expand Regenerative Therapies Nationwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2582872583","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582872583?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:02","pubTimestamp":1762783323,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. has announced a strategic partnership between its research and development division, Adia Labs, and AxiaMD, a provider of nationwide physician oversight and compliance services. Through this collaboration, AxiaMD's network of healthcare providers will gain access to Adia Labs' FDA-compliant regenerative products, while Adia Nutrition's partners and clinics will benefit from AxiaMD's regulatory and physician oversight services. The partnership aims to expand access to advanced regenerative therapies, particularly enabling chiropractic clinics to offer these procedures under full regulatory compliance across all 50 states.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original conten","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDLc5MDjH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"gpt_icon":0},{"id":"2581779926","title":"Adia Nutrition Reports Over 200% Quarterly Revenue Growth and Advances Toward Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581779926","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581779926?lang=en_us&edition=fundamental","pubTime":"2025-11-05 23:01","pubTimestamp":1762354866,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc.  announced key business updates and financial results, highlighting significant growth and strategic progress in 2025. The company reported a revenue surge exceeding 200% quarter-over-quarter in the third quarter, with profit margins above 20%, attributed to strong demand for Adia Med clinics and Adia Labs regenerative products. Adia Nutrition has tripled its sales force and established four regional divisions to enhance nationwide and international distribution. The company also completed the divestiture of its non-core coffee subsidiary, Biolete Coffee, retaining an 18% equity stake. Additionally, Adia Nutrition is preparing to file its SEC Form 10 registration statement by the end of November 2025, aiming for full effectiveness by late January 2026 as part of its strategy to secure a Nasdaq listing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDLZ8WxY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIA","BK4183"],"gpt_icon":0},{"id":"2578395089","title":"Adia Nutrition Reports Over 200% Revenue Growth and 20% Profit Margin in Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2578395089","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578395089?lang=en_us&edition=fundamental","pubTime":"2025-10-28 21:31","pubTimestamp":1761658263,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. has announced an early release of its Q3 financial results, highlighting significant business growth and strong financial performance. The company reported an extraordinary revenue increase of over 200% compared to the previous quarter, along with a net bottom-line profit margin exceeding 20%. Adia Nutrition attributes this success to its bold growth strategy, innovative product portfolio, and focus on value creation for customers and stakeholders. The company's leadership emphasizes that these results reflect its commitment to operational excellence and industry leadership, positioning Adia for continued expansion in the health and wellness sector.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL19hJDc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIA","BK4183"],"gpt_icon":0},{"id":"2577387394","title":"Adia Nutrition Inc. Appoints Dr. Evan Thomas as Medical Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2577387394","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577387394?lang=en_us&edition=fundamental","pubTime":"2025-10-21 21:02","pubTimestamp":1761051724,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. has appointed Dr. Evan Thomas, MD, PhD, as Independent Medical Director for its medical division, Adia Med. Dr. Thomas will oversee clinical operations, including the Autologous Hematopoietic Stem Cell Transplantation  program, and finalize protocols for patient care as the company prepares to expand its specialized treatment offerings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on October 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDL33PjBx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"gpt_icon":0},{"id":"2573923246","title":"Adia Nutrition Inc reports third quarter revenue more than doubles profit margin exceeds 20 percent","url":"https://stock-news.laohu8.com/highlight/detail?id=2573923246","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573923246?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:31","pubTimestamp":1759926660,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. reported preliminary financial results for the third quarter ended September 30, 2025. Revenue increased by more than 100% compared to the second quarter. The company recorded a profit margin exceeding 20% for the quarter. Sales growth was attributed to increased demand across clinical partnerships, direct-to-consumer channels, and national market expansion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on October 08, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nNDL4z88Yh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIA","BK4183"],"gpt_icon":0},{"id":"2573601906","title":"Adia Nutrition Sells Biolete Coffee to Cement Factory LLC, Retains 18% Stake to Focus on Regenerative Medicine Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2573601906","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573601906?lang=en_us&edition=fundamental","pubTime":"2025-10-07 00:39","pubTimestamp":1759768785,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. has sold its Biolete coffee subsidiary to Cement Factory LLC, a consumer products company led by Jeff Sciullo and AJ Sims. As part of the transaction, Adia retains an 18% ownership stake in Cement Factory, maintaining a strategic interest in Biolete's future. The sale allows Adia to sharpen its focus on expanding its regenerative medicine business, including scaling Adia Med clinics, growing its specialized sales force, and advancing treatments for chronic conditions. Proceeds from the sale will support further development of Adia's medical initiatives. Cement Factory plans to build on Biolete's health-focused beverage offerings by enhancing its e-commerce presence and investing in research and development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL7lYln2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"gpt_icon":0},{"id":"2572540754","title":"PAI Partners Closes $4.2 Billion Froneri Equity Deal Backed by Goldman Sachs, ADIA","url":"https://stock-news.laohu8.com/highlight/detail?id=2572540754","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572540754?lang=en_us&edition=fundamental","pubTime":"2025-10-03 03:58","pubTimestamp":1759435116,"startTime":"0","endTime":"0","summary":"A new single-asset continuation vehicle led by Goldman Sachs'  Alternatives division and the Abu Dhabi Investment Authority have invested in ice cream company Froneri, private equity firm PAI Partners said in a statement Thursday.PAI said it has completed a 3.6 billion euros  equity transaction involving the continuation vehicle and ADIA, with the establishment of a new ownership structure for its 50% stake in Froneri.Froneri was formed in 2016 through a 50:50 joint venture to combine PAI's R&R Ice Cream with Nestle's European ice cream business, according to a statement.Goldman Sachs, PAI Partners, and ADIA did not immediately respond to MT Newswires' request for comment.Price: 780.75, Change: -4.76, Percent Change: -0.61","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0061475181.USD","LU1668664300.SGD","LU0251142724.SGD","LU2237443382.USD","LU0106831901.USD","IE00B19Z3B42.SGD","ADIA","LU2237443895.HKD","IE00BFXG1179.USD","LU0742534661.SGD","LU1894683264.USD","BK4504","BK4127","LU0048573561.USD","EQR","BK4215","LU2471134523.USD","LU0345770308.USD","LU2237443622.USD","LU2237443978.SGD","LU1791807156.HKD","LU2265009873.SGD","LU2237443465.HKD","LU0096364046.USD","LU1894683348.USD","LU1868836757.USD","IE00B19Z3581.USD","BK4550","IE00BSNM7G36.USD","LU2471134879.HKD","LU1804176565.USD","LU2750360641.GBP","LU1868837136.USD","IE0004086264.USD","LU2471134952.CNY","PAI","LU2471134796.USD","BK4533","BK4552","LU2750360997.AUD","LU1868836914.USD","LU1868836591.USD","LU2237443549.SGD","BK4588","IE0002270589.USD","BK4516","LU1868837300.USD","IE0034235188.USD","LU2237438978.USD","LU0345770993.USD"],"gpt_icon":0},{"id":"2565503042","title":"Press Release: OHA Secures Significant Commitment from ADIA for European Special Situations Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2565503042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565503042?lang=en_us&edition=fundamental","pubTime":"2025-09-08 15:00","pubTimestamp":1757314800,"startTime":"0","endTime":"0","summary":"London, Sept. 08, 2025  -- Oak Hill Advisors , a leading global credit-focused alternative asset manager, has secured a significant commitment from a wholly owned subsidiary of the Abu Dhabi Investment Authority  for its European special situations strategy. Drawing on OHA's more than 30 years of European credit investing expertise, the strategy will offer flexible and scalable financing solutions tailored to the evolving needs of European corporate and non-corporate borrowers in the current dynamic market environment.Since the inception of its European investment activities in 1992, OHA has deployed over EUR18 billion in the region, including EUR7 billion in private and special situations opportunities. The firm's experienced London-based special situations investment team--co-led by OHA partners Alexis Atteslis and Musa Snmez--are responsible for the execution of the strategy, leveraging deep local sourcing capabilities and proprietary relationships to originate both private capital ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4595","BK4533","BK4600","STRK","BK4588","ADIA","SG9999001440.SGD","BK4023","TROW","BK4516","BK4596","BK4585","BK4135","BK4567"],"gpt_icon":1},{"id":"2564372963","title":"Adia Nutrition Inc. Announces Share Cancellation to Strengthen Capital Structure Amid Ongoing Legal Proceedings","url":"https://stock-news.laohu8.com/highlight/detail?id=2564372963","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564372963?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:46","pubTimestamp":1756989963,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc., a company focused on advancing stem cell therapies, has announced the identification of over 20 million shares that were potentially improperly issued. As part of an ongoing review of its historical share structure, the company has initiated legal proceedings to cancel these shares and return them to its treasury. This action follows a comprehensive internal audit and is supported by the company's legal counsel. Updates on the legal proceedings will be provided as they progress.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on September 04, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL4gy3RV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}